MAGAZYN WOMAN CANCER FORUM – część I: Opisy przypadków pacjentek z zaawansowanym rakiem jajnika leczonych niraparybem w terapii podtrzymującej
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups
Celiac lymph node dissection and peri-hepatic peritonectomy in 10 steps
Carpe diem for same-day discharge following minimally invasive gynecologic oncology surgery
Tubo-ovarian Ewing sarcoma with pseudovascular pattern and hemoperitoneum
Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
